T1	Participants 61 126	patients with hepatitis B e antigen-negative chronic hepatitis B.
T2	Participants 210 236	chronic hepatitis B (CHB).
T3	Participants 458 499	Thirteen patients with HBeAg-negative CHB
T4	Participants 1522 1540	HBeAg-negative CHB
